BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32439287)

  • 1. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence.
    Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J
    Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
    Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
    Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review.
    Dhaliwal S; Kalogeropoulos AP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for Iron Deficiency in Patients With Heart Failure.
    Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
    J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up study.
    Wienbergen H; Pfister O; Hochadel M; Fach A; Backhaus T; Bruder O; Remppis BA; Maeder MT; von Scheidt W; Pauschinger M; Senges J; Hambrecht R;
    Clin Res Cardiol; 2019 Jan; 108(1):93-100. PubMed ID: 30003365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure].
    Mareev YV; Gilarevsky SR; Begrambekova YL; Lopatin YM; Garganeeva AA; Duplyakov DV; Kobalava ZD; Golukhova EZ; Koziolova NA; Panov АV; Lelyavina ТА; Drapkina OM; Mareev VY
    Kardiologiia; 2021 May; 61(4):73-78. PubMed ID: 33998412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
    Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
    Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Iron Deficiency in Heart Failure.
    Zusman O; Itzhaki Ben Zadok O; Gafter-Gvili A
    Acta Haematol; 2019; 142(1):51-56. PubMed ID: 30970349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction.
    Sung HP; Hsu CY; Lee YH; Lin PL; Liao CT; Chung FP; Ko SL; Huang CY; Lin KC; Chang HY
    J Chin Med Assoc; 2023 Aug; 86(8):725-731. PubMed ID: 37314316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
    Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
    Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
    Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group.
    Pezel T; Audureau E; Mansourati J; Baudry G; Ben Driss A; Durup F; Fertin M; Godreuil C; Jeanneteau J; Kloeckner M; Koukoui F; Kesri-Tartière L; Laperche T; Roubille F; Cohen-Solal A; Damy T
    ESC Heart Fail; 2021 Apr; 8(2):1509-1521. PubMed ID: 33619905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
    Silverberg DS; Wexler D; Schwartz D
    Int J Mol Sci; 2015 Jun; 16(6):14056-74. PubMed ID: 26096008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
    Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
    Eur J Heart Fail; 2021 Nov; 23(11):1844-1854. PubMed ID: 34476878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
    López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
    ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Ebner N; Jankowska EA; Ponikowski P; Lainscak M; Elsner S; Sliziuk V; Steinbeck L; Kube J; Bekfani T; Scherbakov N; Valentova M; Sandek A; Doehner W; Springer J; Anker SD; von Haehling S
    Int J Cardiol; 2016 Feb; 205():6-12. PubMed ID: 26705670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency and red cell indices in patients with heart failure.
    Tkaczyszyn M; Comín-Colet J; Voors AA; van Veldhuisen DJ; Enjuanes C; Moliner-Borja P; Rozentryt P; Poloński L; Banasiak W; Ponikowski P; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2018 Jan; 20(1):114-122. PubMed ID: 28386910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we use ferritin in the diagnostic criteria of iron deficiency in heart failure patients?
    Gentil JRS; Fabricio CG; Tanaka DM; Suen VMM; Volpe GJ; Marchini JS; Simões MV
    Clin Nutr ESPEN; 2020 Oct; 39():119-123. PubMed ID: 32859304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.